Active Biotech in brief
Active Biotech is a company with focus on the development of pharmaceutical products within medical areas where the immune defense is of significant importance. Active Biotech operations are currently focused on the laquinimod projects.
The laquinimod projects are focused on the treatment of neurodegenerative/inflammatory diseases. The diseases in which clinical development is ongoing are relapsing remitting multiple sclerosis (RRMS), primary progressive multiple sclerosis (PPMS) and Huntington’s disease (HD). Laquinimod has undergone, and is currently undergoing, a highly comprehensive clinical development program.
In addition, Active Biotech is pursuing a pre-clinical project, ISI. This project has, based on pre-clinical studies, potential treatment applications in both degenerative diseases and cancer.